Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis

There is no targeted therapy for KRAS proto‐oncogene, GTPase (KRAS)‐mutant metastatic colorectal cancer (mCRC) because the underlying mechanism remains obscure. Based on bioinformatic analysis, this study aims to elucidate a potential gene target for which an approved drug is available, and to revea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tianwei, Zhang, Xilin, Ding, Xufen, Feng, Jing, Zhang, Xueli, Xie, Dong, Wang, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061290/
https://www.ncbi.nlm.nih.gov/pubmed/36453019
http://dx.doi.org/10.1002/1878-0261.13350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061290/
https://www.ncbi.nlm.nih.gov/pubmed/36453019
http://dx.doi.org/10.1002/1878-0261.13350

Ejemplares similares